Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

Source: www.arstechnica.com ·
Section: business-tech ·
Bias: Center
· Published: Thu, 22 Oct 2026 22:12:19 GMT
Markers released top-line results today after previously reporting the trial succeeded.
Read the full article at www.arstechnica.com →
The same story across the political spectrum (2 sources)
← Back to FlashTopics.com